S Deblina Datta

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. ncbi Gonorrhea and chlamydia in the United States among persons 14 to 39 years of age, 1999 to 2002
    S Deblina Datta
    Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Ann Intern Med 147:89-96. 2007
  2. ncbi Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003-2005
    S Deblina Datta
    Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Ann Intern Med 148:493-500. 2008
  3. ncbi Chlamydia trachomatis trends in the United States among persons 14 to 39 years of age, 1999-2008
    S Deblina Datta
    National Center for HIV AIDS, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Sex Transm Dis 39:92-6. 2012
  4. ncbi Cervical cancer screening among women who attend sexually transmitted diseases (STD) clinics: background paper for 2010 STD Treatment Guidelines
    S Deblina Datta
    Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Clin Infect Dis 53:S153-9. 2011
  5. ncbi Updates on human papillomavirus and genital warts and counseling messages from the 2010 Sexually Transmitted Diseases Treatment Guidelines
    Eileen F Dunne
    Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 53:S143-52. 2011
  6. ncbi A review of prophylactic human papillomavirus vaccines: recommendations and monitoring in the US
    Eileen F Dunne
    Division of Sexually Transmitted Disease Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30030, USA
    Cancer 113:2995-3003. 2008
  7. ncbi Cancer registries and monitoring the impact of prophylactic human papillomavirus vaccines: the potential role
    Mona Saraiya
    Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia 30030, USA
    Cancer 113:3047-57. 2008
  8. ncbi Post-licensure monitoring of HPV vaccine in the United States
    Lauri E Markowitz
    Centers for Disease Control and Prevention, MS E05, 1600 Clifton Rd, Atlanta, GA 30333, USA
    Vaccine 28:4731-7. 2010
  9. ncbi Prevalence of Neisseria gonorrhoeae among persons 14 to 39 years of age, United States, 1999 to 2008
    Elizabeth A Torrone
    Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Sex Transm Dis 40:202-5. 2013
  10. ncbi Prevalence of sexually transmitted infections among female adolescents aged 14 to 19 in the United States
    Sara E Forhan
    Division of STD Prevention, National Center for HIV, Hepatitis, STD, and Tuberculosis Prevention, Epidemic Intelligence Service, Office of Workforce and Career Development, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Pediatrics 124:1505-12. 2009

Detail Information

Publications12

  1. ncbi Gonorrhea and chlamydia in the United States among persons 14 to 39 years of age, 1999 to 2002
    S Deblina Datta
    Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Ann Intern Med 147:89-96. 2007
    ..Nationally representative surveys of chlamydia and gonorrhea are an important measure of disease burden and progress of screening programs...
  2. ncbi Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003-2005
    S Deblina Datta
    Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Ann Intern Med 148:493-500. 2008
    ..Millions of women in the United States receive cervical screening in sexually transmitted disease (STD), family planning, and primary care clinical settings...
  3. ncbi Chlamydia trachomatis trends in the United States among persons 14 to 39 years of age, 1999-2008
    S Deblina Datta
    National Center for HIV AIDS, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Sex Transm Dis 39:92-6. 2012
    ..We report the first population-based assessment of national trends in chlamydia prevalence in the United States...
  4. ncbi Cervical cancer screening among women who attend sexually transmitted diseases (STD) clinics: background paper for 2010 STD Treatment Guidelines
    S Deblina Datta
    Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Clin Infect Dis 53:S153-9. 2011
    ..This included a review of cervical cancer screening in the STD clinical setting...
  5. ncbi Updates on human papillomavirus and genital warts and counseling messages from the 2010 Sexually Transmitted Diseases Treatment Guidelines
    Eileen F Dunne
    Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 53:S143-52. 2011
    ..At this meeting, there was a discussion of important updates on human papillomavirus (HPV), genital warts, and cervical cancer screening...
  6. ncbi A review of prophylactic human papillomavirus vaccines: recommendations and monitoring in the US
    Eileen F Dunne
    Division of Sexually Transmitted Disease Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30030, USA
    Cancer 113:2995-3003. 2008
    ..In this report, the authors provide a brief review of the epidemiology of HPV infection and an overview of prophylactic HPV vaccines and postvaccine licensure monitoring...
  7. ncbi Cancer registries and monitoring the impact of prophylactic human papillomavirus vaccines: the potential role
    Mona Saraiya
    Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia 30030, USA
    Cancer 113:3047-57. 2008
    ..Collecting type-specific data on HPV-associated precancers and cancers. While keeping in mind the current limitations of registry operations, they discuss resources that may be needed to implement and sustain these types of activities...
  8. ncbi Post-licensure monitoring of HPV vaccine in the United States
    Lauri E Markowitz
    Centers for Disease Control and Prevention, MS E05, 1600 Clifton Rd, Atlanta, GA 30333, USA
    Vaccine 28:4731-7. 2010
    ..We review systems in place or being established for post-licensure monitoring of HPV vaccine in the United States...
  9. ncbi Prevalence of Neisseria gonorrhoeae among persons 14 to 39 years of age, United States, 1999 to 2008
    Elizabeth A Torrone
    Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Sex Transm Dis 40:202-5. 2013
    ..Prevalence estimates from population-based surveys do not suffer from the same biases as case-report and clinic positivity data and may be better to monitor sexually transmitted disease morbidity over time...
  10. ncbi Prevalence of sexually transmitted infections among female adolescents aged 14 to 19 in the United States
    Sara E Forhan
    Division of STD Prevention, National Center for HIV, Hepatitis, STD, and Tuberculosis Prevention, Epidemic Intelligence Service, Office of Workforce and Career Development, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Pediatrics 124:1505-12. 2009
    ..In this study we estimated the prevalence of the most common STIs among a representative sample of female adolescents in the United States...
  11. ncbi Estimates of Chlamydia trachomatis infections among men: United States
    Catherine Lindsey Satterwhite
    Division of STD Prevention, CDC, Atlanta, Georgia 30333, USA
    Sex Transm Dis 35:S3-7. 2008
    ..To describe the epidemiology of genital Chlamydia trachomatis infections among men in the United States...
  12. ncbi Blood exposures and hepatitis C virus infections among emergency responders
    S Deblina Datta
    Division of Viral Hepatitis, National Center for Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA 30030, USA
    Arch Intern Med 163:2605-10. 2003
    ..Testing should routinely be offered to those requiring postexposure management and those with a history of nonoccupational risk factors indicating an increased risk for infection...